SPEAKERS LIVE via WEBCAST
Clinical Trials in a Post-COVID World: 3 Legal Perspectives
Hosted by the Health Care Law Committee
The COVID pandemic caused major disruptions to clinical trial execution in the U.S., impacting key stakeholders across the industry. COVID’s shift to work from home has included a move by sites to enable sponsors to remotely monitor and audit clinical trial studies for regulatory compliance. Attend this timely CLE as panelists explore the impact of COVID on the organization and implementation of clinical trials, including increased cybersecurity considerations, remuneration to participants, and more.
Join your colleagues to understand the challenges of and best practices for conducting clinical trials post-COVID as we collectively journey into the “new normal."
Emily Largent, J.D., Ph.D., RN
Emanuel and Robert Hart Assistant Professor of Medical Ethics and Health Policy
Perelman School of Medicine
Senior Fellow at the Leonard Davis Institute of Health Economics
Center for Health Incentives and Behavioral Economics
Katherine Leibowitz, J.D.
Brad M. Rostolsky, Esq.
Partner, Life Sciences Health Industry Group
Reed Smith, LLP
* This CLE is eligible to be taken for free as part of the six free CLE credits given to members in good standing. To take advantage of this benefit, enter the promo code MBRSFREE21 at checkout.